欧洲 · 通讯社与实时数据 · MarketScreener

Jefferies raises target price for Genmab, boosts view on oncology portfolio

来源：MarketScreener · 法国 13 小时前

Jefferies reiterates its Buy rating on Danish pharmaceutical company Genmab and raises its target price to DKK 3,200 from DKK 2,900. The research firm sees stronger potential for…

在 MarketScreener 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketscreener.com)

Jefferies raises target price for Genmab, boosts view on oncology portfolio

推荐阅读

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

AI gloom revives the specter of stagflation

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long

Jefferies raises target price for Genmab, boosts view on oncology portfolio

分享

推荐阅读

Kremlin aide describes coming week in Putin’s schedule as ‘extremely tight’

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

AI gloom revives the specter of stagflation

FTSE 100 rises as falling oil prices boost risk appetite

Saudi Arabia to store oil in Singapore to bolster Asia supply security

Fed to hit pause on rate hikes, but maybe not for long